Yamazaki, Yusuke
Shiraishi, Yasuyuki
Kohsaka, Shun
Nagatomo, Yuji
Fukuda, Keiichi
Kohno, Takashi
Yoshikawa, Tsutomu
Funding for this research was provided by:
Young Scientists (Y.S. JPSS KAKENHI, 18K15860)
Clinical Research from the Japanese Circulation Society (Y.S. 2019)
Japanese Ministry of Health, Labor and Welfare (S.K. H29-Refractory Disease-034)
the Japan Agency for Medical Research and Development (S.K. 201439013C)
a Health Labor Science Research Grant (S.K. 14528506)
Scientific Research (T.K. 17K09526, T.Y. JPSS KAKENHI, 23591062, 26461088)
Sakakibara Clinical Research Grant for the Promotion of Science (T.Y. 2012 to 2020)
Article History
Received: 5 July 2021
Accepted: 19 August 2021
First Online: 29 September 2021
Competing interests
: The authors stated that no such relationships exist, and provided the following details: Dr. Shiraishi is affiliated with an endowed department by Nippon Shinyaku Co., Ltd., Medtronic Japan Co., Ltd., and BIOTRONIK JAPAN Inc., and received research grants from the SECOM Science and Technology Foundation and the Uehara Memorial Foundation and honoraria from Otsuka Pharmaceuticals Co., Ltd. and Ono Pharmaceuticals Co., Ltd.; and Dr. Kohsaka received an unrestricted research grant from the Department of Cardiology, Keio University School of Medicine, Bayer Pharmaceuticals Co., Ltd., Daiichi Sankyo Co., Ltd., and Novartis Pharma Co., Ltd.. The remaining authors have no conflicts of interest to disclose. There are no patents, products in development, or marketed products to declare.